Concepts (51)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2023 | 14 | 0.210 |
Why?
|
| Stilbenes | 2 | 2019 | 36 | 0.200 |
Why?
|
| Lung Neoplasms | 2 | 2022 | 1590 | 0.190 |
Why?
|
| Molecular Docking Simulation | 1 | 2021 | 110 | 0.180 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2021 | 530 | 0.180 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2021 | 718 | 0.170 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2022 | 121 | 0.170 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2023 | 676 | 0.170 |
Why?
|
| ErbB Receptors | 1 | 2021 | 284 | 0.170 |
Why?
|
| Prostatic Neoplasms | 2 | 2019 | 1545 | 0.170 |
Why?
|
| Sarcoma | 1 | 2022 | 183 | 0.160 |
Why?
|
| Benzofurans | 1 | 2019 | 24 | 0.160 |
Why?
|
| Rhabdomyosarcoma | 1 | 2022 | 191 | 0.160 |
Why?
|
| Vitis | 1 | 2018 | 14 | 0.160 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2022 | 333 | 0.150 |
Why?
|
| Trans-Activators | 2 | 2019 | 799 | 0.150 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2018 | 99 | 0.150 |
Why?
|
| Neuroblastoma | 1 | 2023 | 518 | 0.150 |
Why?
|
| Repressor Proteins | 2 | 2019 | 817 | 0.140 |
Why?
|
| Plant Extracts | 1 | 2018 | 118 | 0.140 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2021 | 870 | 0.130 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2019 | 1888 | 0.100 |
Why?
|
| Cell Line, Tumor | 3 | 2021 | 3328 | 0.080 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2023 | 31 | 0.050 |
Why?
|
| Etanercept | 1 | 2023 | 41 | 0.050 |
Why?
|
| Mice, Inbred NOD | 1 | 2023 | 283 | 0.050 |
Why?
|
| Kelch-Like ECH-Associated Protein 1 | 1 | 2022 | 28 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2022 | 85 | 0.050 |
Why?
|
| Mice, SCID | 1 | 2023 | 565 | 0.050 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2022 | 110 | 0.050 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2022 | 158 | 0.050 |
Why?
|
| Mice | 3 | 2023 | 17582 | 0.050 |
Why?
|
| Protein Isoforms | 1 | 2022 | 406 | 0.040 |
Why?
|
| Monocytes | 1 | 2023 | 350 | 0.040 |
Why?
|
| Carcinogenesis | 1 | 2023 | 332 | 0.040 |
Why?
|
| Powders | 1 | 2018 | 24 | 0.040 |
Why?
|
| Colony-Forming Units Assay | 1 | 2018 | 68 | 0.040 |
Why?
|
| Chemoprevention | 1 | 2018 | 57 | 0.040 |
Why?
|
| Flavonoids | 1 | 2018 | 77 | 0.040 |
Why?
|
| Histone Deacetylases | 1 | 2018 | 110 | 0.040 |
Why?
|
| Mutation | 2 | 2022 | 5827 | 0.040 |
Why?
|
| Humans | 7 | 2023 | 124122 | 0.040 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2022 | 723 | 0.040 |
Why?
|
| Animals | 3 | 2023 | 34002 | 0.030 |
Why?
|
| Cell Survival | 1 | 2018 | 801 | 0.030 |
Why?
|
| Wound Healing | 1 | 2018 | 435 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2018 | 2285 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2022 | 4334 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2019 | 1652 | 0.020 |
Why?
|
| Male | 2 | 2019 | 60978 | 0.010 |
Why?
|
| Female | 1 | 2021 | 66250 | 0.010 |
Why?
|